ReP USP - Resultado da busca

Artigo de periodico
The AT-1 angiotensin receptor is involved in the autonomic and neuroendocrine responses to acute restraint stress in male rats (2022)
Brasil, Taíz Francine Silva; Belém Filho, Ivaldo Jesus Almeida ; Fortaleza, Eduardo Albino Trindade; Antunes-Rodrigues, José; Corrêa, Fernando Morgan de Aguiar
Source: Cellular and Molecular Neurobiology. Unidade: FMRP
Subjects: ANGIOTENSINA II, SISTEMA RENINA-ANGIOTENSINA, SISTEMA NERVOSO AUTÔNOMO, SISTEMA CARDIOVASCULAR, SISTEMA HIPOTÁLAMO-HIPOFISÁRIO, FREQUÊNCIA CARDÍACA, ESTRESSE PSICOLÓGICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRASIL, Taíz Francine Silva et al. The AT-1 angiotensin receptor is involved in the autonomic and neuroendocrine responses to acute restraint stress in male rats. Cellular and Molecular Neurobiology, v. 42, n. 1, p. 109-124, 2022Tradução . . Disponível em: https://doi.org/10.1007/s10571-021-01090-7. Acesso em: 16 nov. 2024.
APA
Brasil, T. F. S., Belém Filho, I. J. A., Fortaleza, E. A. T., Antunes-Rodrigues, J., & Corrêa, F. M. de A. (2022). The AT-1 angiotensin receptor is involved in the autonomic and neuroendocrine responses to acute restraint stress in male rats. Cellular and Molecular Neurobiology, 42( 1), 109-124. doi:10.1007/s10571-021-01090-7
NLM
Brasil TFS, Belém Filho IJA, Fortaleza EAT, Antunes-Rodrigues J, Corrêa FM de A. The AT-1 angiotensin receptor is involved in the autonomic and neuroendocrine responses to acute restraint stress in male rats [Internet]. Cellular and Molecular Neurobiology. 2022 ; 42( 1): 109-124.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s10571-021-01090-7
Vancouver
Brasil TFS, Belém Filho IJA, Fortaleza EAT, Antunes-Rodrigues J, Corrêa FM de A. The AT-1 angiotensin receptor is involved in the autonomic and neuroendocrine responses to acute restraint stress in male rats [Internet]. Cellular and Molecular Neurobiology. 2022 ; 42( 1): 109-124.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s10571-021-01090-7
Artigo de periodico
Angiotensin type 2 receptor antagonism as a new target to manage gout (2022)
Vieira, Thiago Neves; Saraiva, André L. Lopes; Guimarães, Rafaela Mano ; Luiz, João Paulo Mesquita ; Pinto, Larissa Garcia; Ávila, Veridiana de Melo Rodrigues; Goulart, Luiz Ricardo ; Cunha Júnior, Jair Pereira; McNaughton, Peter Anthony; Cunha, Thiago Mattar ; Ferreira, Juliano; Silva, Cássia Regina
Source: Inflammopharmacology. Unidade: FMRP
Subjects: DOR, FARMACOTERAPIA, ANGIOTENSINA II, ANTI-INFLAMATÓRIOS, ANTIOXIDANTES, ARTRITE, ÁCIDO ÚRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIEIRA, Thiago Neves et al. Angiotensin type 2 receptor antagonism as a new target to manage gout. Inflammopharmacology, v. 30, n. 6, p. 2399-2410, 2022Tradução . . Disponível em: https://doi.org/10.1007/s10787-022-01076-x. Acesso em: 16 nov. 2024.
APA
Vieira, T. N., Saraiva, A. L. L., Guimarães, R. M., Luiz, J. P. M., Pinto, L. G., Ávila, V. de M. R., et al. (2022). Angiotensin type 2 receptor antagonism as a new target to manage gout. Inflammopharmacology, 30( 6), 2399-2410. doi:10.1007/s10787-022-01076-x
NLM
Vieira TN, Saraiva ALL, Guimarães RM, Luiz JPM, Pinto LG, Ávila V de MR, Goulart LR, Cunha Júnior JP, McNaughton PA, Cunha TM, Ferreira J, Silva CR. Angiotensin type 2 receptor antagonism as a new target to manage gout [Internet]. Inflammopharmacology. 2022 ; 30( 6): 2399-2410.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s10787-022-01076-x
Vancouver
Vieira TN, Saraiva ALL, Guimarães RM, Luiz JPM, Pinto LG, Ávila V de MR, Goulart LR, Cunha Júnior JP, McNaughton PA, Cunha TM, Ferreira J, Silva CR. Angiotensin type 2 receptor antagonism as a new target to manage gout [Internet]. Inflammopharmacology. 2022 ; 30( 6): 2399-2410.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s10787-022-01076-x
Artigo de periodico
Angiotensin-II activates vascular inflammasome and induces vascular damage (2021)
Cáu, Stêfany Bruno de Assis; Bruder-Nascimento, Ariane; Silva, Marcondes Alves Barbosa da; Ramalho, Fernanda Naira Zambelli; Mestriner, Fabiola Leslie Antunes Cardoso; Lopes, Rheure Alves Moreira; Ferreira, Nathanne dos Santos; Tostes, Rita de Cássia Aleixo ; Nascimento, Thiago Bruder do
Source: Vascular Pharmacology. Unidade: FMRP
Subjects: ANGIOTENSINA II, CÉLULAS CULTIVADAS, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CÁU, Stêfany Bruno de Assis et al. Angiotensin-II activates vascular inflammasome and induces vascular damage. Vascular Pharmacology, v. 139, p. 1-10, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.vph.2021.106881. Acesso em: 16 nov. 2024.
APA
Cáu, S. B. de A., Bruder-Nascimento, A., Silva, M. A. B. da, Ramalho, F. N. Z., Mestriner, F. L. A. C., Lopes, R. A. M., et al. (2021). Angiotensin-II activates vascular inflammasome and induces vascular damage. Vascular Pharmacology, 139, 1-10. doi:10.1016/j.vph.2021.106881
NLM
Cáu SB de A, Bruder-Nascimento A, Silva MAB da, Ramalho FNZ, Mestriner FLAC, Lopes RAM, Ferreira N dos S, Tostes R de CA, Nascimento TB do. Angiotensin-II activates vascular inflammasome and induces vascular damage [Internet]. Vascular Pharmacology. 2021 ; 139 1-10.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.vph.2021.106881
Vancouver
Cáu SB de A, Bruder-Nascimento A, Silva MAB da, Ramalho FNZ, Mestriner FLAC, Lopes RAM, Ferreira N dos S, Tostes R de CA, Nascimento TB do. Angiotensin-II activates vascular inflammasome and induces vascular damage [Internet]. Vascular Pharmacology. 2021 ; 139 1-10.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.vph.2021.106881
Artigo de periodico
Oral nitrite treatment increases S-nitrosylation of vascular protein kinase C and attenuates the responses to angiotensin II (2021)
Pinheiro, Lucas Cezar ; Oliveira-Paula, Gustavo Henrique; Ferreira, Graziele Cristina ; Paula, Tiago Dal-Cin de; Duarte, Diego Ângelo; Costa Neto, Cláudio Miguel; Tanus-Santos, José Eduardo
Source: Redox Report. Unidades: EERP, FMRP
Subjects: ANGIOTENSINA II, ÓXIDO NÍTRICO, NITRITOS, PROTEÍNAS QUINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINHEIRO, Lucas Cezar et al. Oral nitrite treatment increases S-nitrosylation of vascular protein kinase C and attenuates the responses to angiotensin II. Redox Report, v. 38, p. 1-11, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.redox.2020.101769. Acesso em: 16 nov. 2024.
APA
Pinheiro, L. C., Oliveira-Paula, G. H., Ferreira, G. C., Paula, T. D. -C. de, Duarte, D. Â., Costa Neto, C. M., & Tanus-Santos, J. E. (2021). Oral nitrite treatment increases S-nitrosylation of vascular protein kinase C and attenuates the responses to angiotensin II. Redox Report, 38, 1-11. doi:10.1016/j.redox.2020.101769
NLM
Pinheiro LC, Oliveira-Paula GH, Ferreira GC, Paula TD-C de, Duarte DÂ, Costa Neto CM, Tanus-Santos JE. Oral nitrite treatment increases S-nitrosylation of vascular protein kinase C and attenuates the responses to angiotensin II [Internet]. Redox Report. 2021 ; 38 1-11.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.redox.2020.101769
Vancouver
Pinheiro LC, Oliveira-Paula GH, Ferreira GC, Paula TD-C de, Duarte DÂ, Costa Neto CM, Tanus-Santos JE. Oral nitrite treatment increases S-nitrosylation of vascular protein kinase C and attenuates the responses to angiotensin II [Internet]. Redox Report. 2021 ; 38 1-11.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.redox.2020.101769
Artigo de periodico
Blockade of bradykinin receptors or angiotensin II type 2 receptor prevents paclitaxel‐associated acute pain syndrome in mice (2021)
Zanata, Graziele C.; Pinto, Larissa G.; Silva, Nicole Rodrigues da; Lopes, Alexandre Hashimoto Pereira; Oliveira, Francisco Fábio Bezerra; Schivo, Ieda Regina dos Santos; Cunha, Fernando de Queiroz ; McNaughton, Peter; Cunha, Thiago Mattar; Silva, Rangel Leal
Source: European Journal of Pain. Unidade: FMRP
Subjects: BLOQUEADORES NEUROMUSCULARES, ANGIOTENSINA II, BRADICININA, GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZANATA, Graziele C. et al. Blockade of bradykinin receptors or angiotensin II type 2 receptor prevents paclitaxel‐associated acute pain syndrome in mice. European Journal of Pain, v. 25, n. 1, p. 189-198, 2021Tradução . . Disponível em: https://doi.org/10.1002/ejp.1660. Acesso em: 16 nov. 2024.
APA
Zanata, G. C., Pinto, L. G., Silva, N. R. da, Lopes, A. H. P., Oliveira, F. F. B., Schivo, I. R. dos S., et al. (2021). Blockade of bradykinin receptors or angiotensin II type 2 receptor prevents paclitaxel‐associated acute pain syndrome in mice. European Journal of Pain, 25( 1), 189-198. doi:10.1002/ejp.1660
NLM
Zanata GC, Pinto LG, Silva NR da, Lopes AHP, Oliveira FFB, Schivo IR dos S, Cunha F de Q, McNaughton P, Cunha TM, Silva RL. Blockade of bradykinin receptors or angiotensin II type 2 receptor prevents paclitaxel‐associated acute pain syndrome in mice [Internet]. European Journal of Pain. 2021 ; 25( 1): 189-198.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/ejp.1660
Vancouver
Zanata GC, Pinto LG, Silva NR da, Lopes AHP, Oliveira FFB, Schivo IR dos S, Cunha F de Q, McNaughton P, Cunha TM, Silva RL. Blockade of bradykinin receptors or angiotensin II type 2 receptor prevents paclitaxel‐associated acute pain syndrome in mice [Internet]. European Journal of Pain. 2021 ; 25( 1): 189-198.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/ejp.1660
Artigo de periodico
SARS-CoV-2–triggered neutrophil extracellular traps mediate COVID-19 pathology (2020)
Veras, Flavio Protasio; Pontelli, Marjorie Cornejo ; Silva, Camila Meirelles de Souza; Toller-Kawahisa, Juliana E.; Lima, Mikhael de; Nascimento, Daniele Carvalho; Schneider, Ayda Henriques; Caetité, Diego; Tavares, Lucas Alves ; Paiva, Isadora M.; Rosales, Roberta Ribeiro Costa; morelo, David Fernando Colon ; Martins, Ronaldo Bragança ; Castro, Ítalo Araújo de ; Almeida, Glaucia Maria ; Lopes, Maria Isabel Fernandes; Benatti, Maíra Nilson; Bonjorno, Letícia Pastorelli; Giannini, Marcela Cavichioli; Luppino-Assad, Rodrigo; Almeida, Sérgio Luna; Vilar, Fernando; Santana, Rodrigo de Carvalho ; Bollela, Valdes Roberto ; Auxiliadora-Martins, Maria ; Borges, Marcos de Carvalho ; Miranda, Carlos Henrique ; Pazin Filho, Antônio ; Silva, Luis Lamberti Pinto da ; Cunha, Larissa Dias; Zamboni, Dario Simões ; Dal-Pizzol, Felipe; Leiria, Luiz Osório Silveira ; Siyuan, Li; Batah, Sabrina Setembre ; Fabro, Alexandre Todorovic ; Mauad, Thais ; Dolhnikoff, Marisa ; Duarte Neto, Amaro Nunes ; Saldiva, Paulo Hilário Nascimento ; Cunha, Thiago Mattar ; Alves Filho, José Carlos Farias ; Arruda, Eurico ; Louzada Júnior, Paulo ; Oliveira, Renê Donizeti; Cunha, Fernando de Queiroz
Source: Journal of Experimental Medicine. Unidades: FMRP, FM
Subjects: COVID-19, CÉLULAS EPITELIAIS, PATOLOGIA, VIROLOGIA, PNEUMONIA, NEUTRÓFILOS, ANGIOTENSINA II
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VERAS, Flavio Protasio et al. SARS-CoV-2–triggered neutrophil extracellular traps mediate COVID-19 pathology. Journal of Experimental Medicine, v. 217, n. 12, 2020Tradução . . Disponível em: https://doi.org/10.1084/jem.20201129. Acesso em: 16 nov. 2024.
APA
Veras, F. P., Pontelli, M. C., Silva, C. M. de S., Toller-Kawahisa, J. E., Lima, M. de, Nascimento, D. C., et al. (2020). SARS-CoV-2–triggered neutrophil extracellular traps mediate COVID-19 pathology. Journal of Experimental Medicine, 217( 12). doi:10.1084/jem.20201129
NLM
Veras FP, Pontelli MC, Silva CM de S, Toller-Kawahisa JE, Lima M de, Nascimento DC, Schneider AH, Caetité D, Tavares LA, Paiva IM, Rosales RRC, morelo DFC, Martins RB, Castro ÍA de, Almeida GM, Lopes MIF, Benatti MN, Bonjorno LP, Giannini MC, Luppino-Assad R, Almeida SL, Vilar F, Santana R de C, Bollela VR, Auxiliadora-Martins M, Borges M de C, Miranda CH, Pazin Filho A, Silva LLP da, Cunha LD, Zamboni DS, Dal-Pizzol F, Leiria LOS, Siyuan L, Batah SS, Fabro AT, Mauad T, Dolhnikoff M, Duarte Neto AN, Saldiva PHN, Cunha TM, Alves Filho JCF, Arruda E, Louzada Júnior P, Oliveira RD, Cunha F de Q. SARS-CoV-2–triggered neutrophil extracellular traps mediate COVID-19 pathology [Internet]. Journal of Experimental Medicine. 2020 ; 217( 12):[citado 2024 nov. 16 ] Available from: https://doi.org/10.1084/jem.20201129
Vancouver
Veras FP, Pontelli MC, Silva CM de S, Toller-Kawahisa JE, Lima M de, Nascimento DC, Schneider AH, Caetité D, Tavares LA, Paiva IM, Rosales RRC, morelo DFC, Martins RB, Castro ÍA de, Almeida GM, Lopes MIF, Benatti MN, Bonjorno LP, Giannini MC, Luppino-Assad R, Almeida SL, Vilar F, Santana R de C, Bollela VR, Auxiliadora-Martins M, Borges M de C, Miranda CH, Pazin Filho A, Silva LLP da, Cunha LD, Zamboni DS, Dal-Pizzol F, Leiria LOS, Siyuan L, Batah SS, Fabro AT, Mauad T, Dolhnikoff M, Duarte Neto AN, Saldiva PHN, Cunha TM, Alves Filho JCF, Arruda E, Louzada Júnior P, Oliveira RD, Cunha F de Q. SARS-CoV-2–triggered neutrophil extracellular traps mediate COVID-19 pathology [Internet]. Journal of Experimental Medicine. 2020 ; 217( 12):[citado 2024 nov. 16 ] Available from: https://doi.org/10.1084/jem.20201129
Artigo de periodico
Angiotensin (1-7)-attenuated vasoconstriction is associated with the interleukin-10 signaling pathway (2020)
Freitas, Raiany Alves de; Júnior, Roberto R. P.; Justina, Vanessa Dela; Bressan, Alecsander Fabrício Moreira ; Bomfim, Gisele Facholi; Carneiro, Fernando Silva ; Giachini, Fernanda Regina; Lima, Victor Vitorino
Source: Life Sciences. Unidade: FMRP
Subjects: ANGIOTENSINAS, ANGIOTENSINA II, SISTEMA RENINA-ANGIOTENSINA, FOSFATASE ALCALINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FREITAS, Raiany Alves de et al. Angiotensin (1-7)-attenuated vasoconstriction is associated with the interleukin-10 signaling pathway. Life Sciences, v. 262, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.lfs.2020.118552. Acesso em: 16 nov. 2024.
APA
Freitas, R. A. de, Júnior, R. R. P., Justina, V. D., Bressan, A. F. M., Bomfim, G. F., Carneiro, F. S., et al. (2020). Angiotensin (1-7)-attenuated vasoconstriction is associated with the interleukin-10 signaling pathway. Life Sciences, 262. doi:10.1016/j.lfs.2020.118552
NLM
Freitas RA de, Júnior RRP, Justina VD, Bressan AFM, Bomfim GF, Carneiro FS, Giachini FR, Lima VV. Angiotensin (1-7)-attenuated vasoconstriction is associated with the interleukin-10 signaling pathway [Internet]. Life Sciences. 2020 ; 262[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.lfs.2020.118552
Vancouver
Freitas RA de, Júnior RRP, Justina VD, Bressan AFM, Bomfim GF, Carneiro FS, Giachini FR, Lima VV. Angiotensin (1-7)-attenuated vasoconstriction is associated with the interleukin-10 signaling pathway [Internet]. Life Sciences. 2020 ; 262[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.lfs.2020.118552
Artigo de periodico
Nitroxyl anion mediates relaxation in mesenteric arteries from angiotensin II hypertensive mice (2018)
Wynne, Brandi M.; Labazi, Hicham; Passaglia, Rita de Cássia Aleixo Tostes; Webb, R. Clinton
Source: Current Vascular Pharmacology. Unidade: FMRP
Subjects: HIPERTENSÃO, RATOS, ÓXIDO NÍTRICO, ANGIOTENSINA II
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WYNNE, Brandi M. et al. Nitroxyl anion mediates relaxation in mesenteric arteries from angiotensin II hypertensive mice. Current Vascular Pharmacology, v. 16, n. 1, p. 93-101, 2018Tradução . . Disponível em: https://doi.org/10.2174/1570161115666170725151509. Acesso em: 16 nov. 2024.
APA
Wynne, B. M., Labazi, H., Passaglia, R. de C. A. T., & Webb, R. C. (2018). Nitroxyl anion mediates relaxation in mesenteric arteries from angiotensin II hypertensive mice. Current Vascular Pharmacology, 16( 1), 93-101. doi:10.2174/1570161115666170725151509
NLM
Wynne BM, Labazi H, Passaglia R de CAT, Webb RC. Nitroxyl anion mediates relaxation in mesenteric arteries from angiotensin II hypertensive mice [Internet]. Current Vascular Pharmacology. 2018 ; 16( 1): 93-101.[citado 2024 nov. 16 ] Available from: https://doi.org/10.2174/1570161115666170725151509
Vancouver
Wynne BM, Labazi H, Passaglia R de CAT, Webb RC. Nitroxyl anion mediates relaxation in mesenteric arteries from angiotensin II hypertensive mice [Internet]. Current Vascular Pharmacology. 2018 ; 16( 1): 93-101.[citado 2024 nov. 16 ] Available from: https://doi.org/10.2174/1570161115666170725151509
Artigo de periodico
Elastase-2, an angiotensin II-generating enzyme, contributes to increased angiotensin II in resistance arteries of mice with myocardial infarction (2017)
Becari, Christiane; Silva, Marcondes Alves Barbosa da; Durand, Marina Toledo; Prado, Cibele Maria; Oliveira, Eduardo Brandt de; Ribeiro, Maurício Serra; Salgado, Hélio César; Salgado, Maria Cristina de Oliveira; Tostes, Rita de Cássia Aleixo
Source: British Journal of Pharmacology. Unidade: FMRP
Subjects: ANGIOTENSINA II, VASOS CORONÁRIOS, INFARTO DO MIOCÁRDIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BECARI, Christiane et al. Elastase-2, an angiotensin II-generating enzyme, contributes to increased angiotensin II in resistance arteries of mice with myocardial infarction. British Journal of Pharmacology, v. 174, n. 10, p. 1104-1115, 2017Tradução . . Disponível em: https://doi.org/10.1111/bph.13755. Acesso em: 16 nov. 2024.
APA
Becari, C., Silva, M. A. B. da, Durand, M. T., Prado, C. M., Oliveira, E. B. de, Ribeiro, M. S., et al. (2017). Elastase-2, an angiotensin II-generating enzyme, contributes to increased angiotensin II in resistance arteries of mice with myocardial infarction. British Journal of Pharmacology, 174( 10), 1104-1115. doi:10.1111/bph.13755
NLM
Becari C, Silva MAB da, Durand MT, Prado CM, Oliveira EB de, Ribeiro MS, Salgado HC, Salgado MC de O, Tostes R de CA. Elastase-2, an angiotensin II-generating enzyme, contributes to increased angiotensin II in resistance arteries of mice with myocardial infarction [Internet]. British Journal of Pharmacology. 2017 ; 174( 10): 1104-1115.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/bph.13755
Vancouver
Becari C, Silva MAB da, Durand MT, Prado CM, Oliveira EB de, Ribeiro MS, Salgado HC, Salgado MC de O, Tostes R de CA. Elastase-2, an angiotensin II-generating enzyme, contributes to increased angiotensin II in resistance arteries of mice with myocardial infarction [Internet]. British Journal of Pharmacology. 2017 ; 174( 10): 1104-1115.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/bph.13755
Artigo de periodico
Chronic restraint stress increases angiotensin II potency in the rat carotid: role of cyclooxygenases and reactive oxygen species (2017)
Côco, Hariane; Pernomian, Larissa; Pereira, Priscila C.; Gomes, Mayara Santos; Marchi, Katia C.; Lopes, Alexandre H.; Cunha, Thiago Mattar; Tirapelli, Carlos Renato ; Oliveira, Ana Maria de
Source: Journal of Pharmacy and Pharmacology. Unidades: FCFRP, FMRP, EERP
Subjects: ANGIOTENSINA II, ARTÉRIAS CARÓTIDAS, ENDOTÉLIO VASCULAR, ESTRESSE PSICOLÓGICO, ESPÉCIES REATIVAS DE OXIGÊNIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CÔCO, Hariane et al. Chronic restraint stress increases angiotensin II potency in the rat carotid: role of cyclooxygenases and reactive oxygen species. Journal of Pharmacy and Pharmacology, v. 69, n. 1, p. 52-65, 2017Tradução . . Disponível em: https://doi.org/10.1111/jphp.12659. Acesso em: 16 nov. 2024.
APA
Côco, H., Pernomian, L., Pereira, P. C., Gomes, M. S., Marchi, K. C., Lopes, A. H., et al. (2017). Chronic restraint stress increases angiotensin II potency in the rat carotid: role of cyclooxygenases and reactive oxygen species. Journal of Pharmacy and Pharmacology, 69( 1), 52-65. doi:10.1111/jphp.12659
NLM
Côco H, Pernomian L, Pereira PC, Gomes MS, Marchi KC, Lopes AH, Cunha TM, Tirapelli CR, Oliveira AM de. Chronic restraint stress increases angiotensin II potency in the rat carotid: role of cyclooxygenases and reactive oxygen species [Internet]. Journal of Pharmacy and Pharmacology. 2017 ; 69( 1): 52-65.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/jphp.12659
Vancouver
Côco H, Pernomian L, Pereira PC, Gomes MS, Marchi KC, Lopes AH, Cunha TM, Tirapelli CR, Oliveira AM de. Chronic restraint stress increases angiotensin II potency in the rat carotid: role of cyclooxygenases and reactive oxygen species [Internet]. Journal of Pharmacy and Pharmacology. 2017 ; 69( 1): 52-65.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/jphp.12659
Artigo de periodico
Ang-(1-7) is an endogenous β-arrestin-biased agonist of the AT1 receptor with protective action in cardiac hypertrophy (2017)
Teixeira, Larissa B.; Parreiras-e-Silva, Lucas T.; Bruder-Nascimento, Thiago; Duarte, Diego A.; Simões, Sarah C.; Costa, Rafael M.; Rodríguez, Deisy Y.; Ferreira, Pedro A. B.; Silva, Carlos Alberto Aguiar da; Abrao, Emiliana P.; Oliveira, Eduardo Brandt de; Bouvier, Michel; Tostes, Rita de Cássia Aleixo; Costa Neto, Cláudio Miguel
Source: Scientific Reports. Unidade: FMRP
Subjects: SISTEMA RENINA-ANGIOTENSINA, ANGIOTENSINAS, ANGIOTENSINA II, SISTEMA CARDIOVASCULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TEIXEIRA, Larissa B. et al. Ang-(1-7) is an endogenous β-arrestin-biased agonist of the AT1 receptor with protective action in cardiac hypertrophy. Scientific Reports, v. 7, n. 1, 2017Tradução . . Disponível em: https://doi.org/10.1038/s41598-017-12074-3. Acesso em: 16 nov. 2024.
APA
Teixeira, L. B., Parreiras-e-Silva, L. T., Bruder-Nascimento, T., Duarte, D. A., Simões, S. C., Costa, R. M., et al. (2017). Ang-(1-7) is an endogenous β-arrestin-biased agonist of the AT1 receptor with protective action in cardiac hypertrophy. Scientific Reports, 7( 1). doi:10.1038/s41598-017-12074-3
NLM
Teixeira LB, Parreiras-e-Silva LT, Bruder-Nascimento T, Duarte DA, Simões SC, Costa RM, Rodríguez DY, Ferreira PAB, Silva CAA da, Abrao EP, Oliveira EB de, Bouvier M, Tostes R de CA, Costa Neto CM. Ang-(1-7) is an endogenous β-arrestin-biased agonist of the AT1 receptor with protective action in cardiac hypertrophy [Internet]. Scientific Reports. 2017 ; 7( 1):[citado 2024 nov. 16 ] Available from: https://doi.org/10.1038/s41598-017-12074-3
Vancouver
Teixeira LB, Parreiras-e-Silva LT, Bruder-Nascimento T, Duarte DA, Simões SC, Costa RM, Rodríguez DY, Ferreira PAB, Silva CAA da, Abrao EP, Oliveira EB de, Bouvier M, Tostes R de CA, Costa Neto CM. Ang-(1-7) is an endogenous β-arrestin-biased agonist of the AT1 receptor with protective action in cardiac hypertrophy [Internet]. Scientific Reports. 2017 ; 7( 1):[citado 2024 nov. 16 ] Available from: https://doi.org/10.1038/s41598-017-12074-3
Artigo de periodico
Interleukin-10 limits increased blood pressure and vascular RhoA/Rho-kinase signaling in angiotensin II-infused mice (2016)
Lima, Victor V; Zemse, Saiprasad M; Chiao, Chin-Wei; Bomfim, Gisele F; Tostes, Rita de Cássia Aleixo; Webb, R. Clinton; Giachini, Fernanda R
Source: Life Sciences. Unidade: FMRP
Subjects: HIPERTENSÃO, INFLAMAÇÃO, INTERLEUCINA-10, ANGIOTENSINA II, AORTA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Victor V et al. Interleukin-10 limits increased blood pressure and vascular RhoA/Rho-kinase signaling in angiotensin II-infused mice. Life Sciences, v. 145, p. 137-143, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.lfs.2015.12.009. Acesso em: 16 nov. 2024.
APA
Lima, V. V., Zemse, S. M., Chiao, C. -W., Bomfim, G. F., Tostes, R. de C. A., Webb, R. C., & Giachini, F. R. (2016). Interleukin-10 limits increased blood pressure and vascular RhoA/Rho-kinase signaling in angiotensin II-infused mice. Life Sciences, 145, 137-143. doi:10.1016/j.lfs.2015.12.009
NLM
Lima VV, Zemse SM, Chiao C-W, Bomfim GF, Tostes R de CA, Webb RC, Giachini FR. Interleukin-10 limits increased blood pressure and vascular RhoA/Rho-kinase signaling in angiotensin II-infused mice [Internet]. Life Sciences. 2016 ; 145 137-143.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.lfs.2015.12.009
Vancouver
Lima VV, Zemse SM, Chiao C-W, Bomfim GF, Tostes R de CA, Webb RC, Giachini FR. Interleukin-10 limits increased blood pressure and vascular RhoA/Rho-kinase signaling in angiotensin II-infused mice [Internet]. Life Sciences. 2016 ; 145 137-143.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.lfs.2015.12.009
Trabalho de evento-resumo
Downregulation of vascular factor‐erythroid 2‐related factor‐2 and associated antioxidant enzymes in hypertension (2014)
Lopes, Rheure A.; Neves, Karla B.; Montezano, Augusto; Passaglia, Rita de Cassia Aleixo Tostes; Touyz, Rhian
Source: Final Program. Conference titles: High Blood Pressure Research Scientific Sessions - HBPR. Unidade: FMRP
Subjects: HIPERTENSÃO, ANGIOTENSINA II, ESTRESSE OXIDATIVO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOPES, Rheure A. et al. Downregulation of vascular factor‐erythroid 2‐related factor‐2 and associated antioxidant enzymes in hypertension. 2014, Anais.. San Francisco: AHA, 2014. Disponível em: http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_468057.pdf. Acesso em: 16 nov. 2024.
APA
Lopes, R. A., Neves, K. B., Montezano, A., Passaglia, R. de C. A. T., & Touyz, R. (2014). Downregulation of vascular factor‐erythroid 2‐related factor‐2 and associated antioxidant enzymes in hypertension. In Final Program. San Francisco: AHA. Recuperado de http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_468057.pdf
NLM
Lopes RA, Neves KB, Montezano A, Passaglia R de CAT, Touyz R. Downregulation of vascular factor‐erythroid 2‐related factor‐2 and associated antioxidant enzymes in hypertension [Internet]. Final Program. 2014 ;[citado 2024 nov. 16 ] Available from: http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_468057.pdf
Vancouver
Lopes RA, Neves KB, Montezano A, Passaglia R de CAT, Touyz R. Downregulation of vascular factor‐erythroid 2‐related factor‐2 and associated antioxidant enzymes in hypertension [Internet]. Final Program. 2014 ;[citado 2024 nov. 16 ] Available from: http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_468057.pdf
Trabalho de evento-resumo periodico
Downregulation of vascular factor-erythroid 2-related factor-2 and associated antioxidant enzymes in hypertension (2014)
Lopes, Rheure A.; Neves, Karla B.; Montezano, Augusto; Passaglia, Rita de Cassia Aleixo Tostes; Touyz, Rhian
Source: Hypertension. Conference titles: High Blood Pressure Research Scientific Sessions - HBPR. Unidade: FMRP
Subjects: HIPERTENSÃO, ANGIOTENSINA II, ESTRESSE OXIDATIVO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOPES, Rheure A. et al. Downregulation of vascular factor-erythroid 2-related factor-2 and associated antioxidant enzymes in hypertension. Hypertension. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: http://hyper.ahajournals.org/content/64/Suppl_1/A067.abstract?sid=55a5cbeb-11f8-41eb-96b5-1ce5c09bae04. Acesso em: 16 nov. 2024. , 2014
APA
Lopes, R. A., Neves, K. B., Montezano, A., Passaglia, R. de C. A. T., & Touyz, R. (2014). Downregulation of vascular factor-erythroid 2-related factor-2 and associated antioxidant enzymes in hypertension. Hypertension. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Recuperado de http://hyper.ahajournals.org/content/64/Suppl_1/A067.abstract?sid=55a5cbeb-11f8-41eb-96b5-1ce5c09bae04
NLM
Lopes RA, Neves KB, Montezano A, Passaglia R de CAT, Touyz R. Downregulation of vascular factor-erythroid 2-related factor-2 and associated antioxidant enzymes in hypertension [Internet]. Hypertension. 2014 ; 64[citado 2024 nov. 16 ] Available from: http://hyper.ahajournals.org/content/64/Suppl_1/A067.abstract?sid=55a5cbeb-11f8-41eb-96b5-1ce5c09bae04
Vancouver
Lopes RA, Neves KB, Montezano A, Passaglia R de CAT, Touyz R. Downregulation of vascular factor-erythroid 2-related factor-2 and associated antioxidant enzymes in hypertension [Internet]. Hypertension. 2014 ; 64[citado 2024 nov. 16 ] Available from: http://hyper.ahajournals.org/content/64/Suppl_1/A067.abstract?sid=55a5cbeb-11f8-41eb-96b5-1ce5c09bae04
Artigo de periodico
Metformin treatment improves erectile function in an angiotensin II model of erectile dysfunction (2013)
Labazi, Hicham; Wynne, Brandi M.; Tostes, Rita de Cassia Aleixo; Webb, R. Clinton
Source: Journal of Sexual Medicine. Unidade: FMRP
Subjects: ANGIOTENSINA II, HIPERTENSÃO, DISFUNÇÃO ERÉTIL, MODELOS ANIMAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LABAZI, Hicham et al. Metformin treatment improves erectile function in an angiotensin II model of erectile dysfunction. Journal of Sexual Medicine, v. 10, n. 9, p. 2154-2164, 2013Tradução . . Disponível em: https://doi.org/10.1111/jsm.12245. Acesso em: 16 nov. 2024.
APA
Labazi, H., Wynne, B. M., Tostes, R. de C. A., & Webb, R. C. (2013). Metformin treatment improves erectile function in an angiotensin II model of erectile dysfunction. Journal of Sexual Medicine, 10( 9), 2154-2164. doi:10.1111/jsm.12245
NLM
Labazi H, Wynne BM, Tostes R de CA, Webb RC. Metformin treatment improves erectile function in an angiotensin II model of erectile dysfunction [Internet]. Journal of Sexual Medicine. 2013 ; 10( 9): 2154-2164.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/jsm.12245
Vancouver
Labazi H, Wynne BM, Tostes R de CA, Webb RC. Metformin treatment improves erectile function in an angiotensin II model of erectile dysfunction [Internet]. Journal of Sexual Medicine. 2013 ; 10( 9): 2154-2164.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/jsm.12245
Artigo de periodico
Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling (2013)
Martins-Oliveira, Alisson; Castro, Michele Mazzaron de; Oliveira, Diogo M. M.; Rizzi, Elen; Ceron, Carla S.; Guimarães, Danielle; Reis, Rosana I.; Costa Neto, Claudio Miguel da; Casarini, Dulce E.; Ribeiro, Amanda A.; Gerlach, Raquel Fernanda; Tanus-Santos, José Eduardo
Source: International Journal of Cardiology. Unidades: FMRP, FORP
Subjects: ANGIOTENSINA II, HIPERTENSÃO, METALOPROTEINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTINS-OLIVEIRA, Alisson et al. Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling. International Journal of Cardiology, v. 167, n. 4, p. 1199-1205, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.ijcard.2012.03.137. Acesso em: 16 nov. 2024.
APA
Martins-Oliveira, A., Castro, M. M. de, Oliveira, D. M. M., Rizzi, E., Ceron, C. S., Guimarães, D., et al. (2013). Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling. International Journal of Cardiology, 167( 4), 1199-1205. doi:10.1016/j.ijcard.2012.03.137
NLM
Martins-Oliveira A, Castro MM de, Oliveira DMM, Rizzi E, Ceron CS, Guimarães D, Reis RI, Costa Neto CM da, Casarini DE, Ribeiro AA, Gerlach RF, Tanus-Santos JE. Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling [Internet]. International Journal of Cardiology. 2013 ; 167( 4): 1199-1205.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.ijcard.2012.03.137
Vancouver
Martins-Oliveira A, Castro MM de, Oliveira DMM, Rizzi E, Ceron CS, Guimarães D, Reis RI, Costa Neto CM da, Casarini DE, Ribeiro AA, Gerlach RF, Tanus-Santos JE. Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling [Internet]. International Journal of Cardiology. 2013 ; 167( 4): 1199-1205.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.ijcard.2012.03.137
Artigo de periodico
Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling (2013)
Martins-Oliveira, Alisson; Castro, Michele M.; Oliveira, Diogo M. M.; Rizzi, Elen; Ceron, Carla S.; Guimarães, Danielle; Reis, Rosana I.; Costa Neto, Cláudio Miguel; Casarini, Dulce E.; Ribeiro, Amanda A.; Gerlach, Raquel Fernanda; Santos, José Eduardo Tanus dos
Source: International Journal of Cardiology. Unidades: FMRP, FORP
Subjects: HIPERTENSÃO, ANGIOTENSINA II, METALOPROTEINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTINS-OLIVEIRA, Alisson et al. Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling. International Journal of Cardiology, v. 167, n. 4, p. 1199-1205, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.ijcard.2012.03.137. Acesso em: 16 nov. 2024.
APA
Martins-Oliveira, A., Castro, M. M., Oliveira, D. M. M., Rizzi, E., Ceron, C. S., Guimarães, D., et al. (2013). Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling. International Journal of Cardiology, 167( 4), 1199-1205. doi:10.1016/j.ijcard.2012.03.137
NLM
Martins-Oliveira A, Castro MM, Oliveira DMM, Rizzi E, Ceron CS, Guimarães D, Reis RI, Costa Neto CM, Casarini DE, Ribeiro AA, Gerlach RF, Santos JET dos. Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling [Internet]. International Journal of Cardiology. 2013 ; 167( 4): 1199-1205.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.ijcard.2012.03.137
Vancouver
Martins-Oliveira A, Castro MM, Oliveira DMM, Rizzi E, Ceron CS, Guimarães D, Reis RI, Costa Neto CM, Casarini DE, Ribeiro AA, Gerlach RF, Santos JET dos. Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling [Internet]. International Journal of Cardiology. 2013 ; 167( 4): 1199-1205.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.ijcard.2012.03.137
Artigo de periodico
Aorta from angiotensin II hypertensive mice exhibit preserved nitroxyl anion mediated relaxation responses (2012)
Wynne, Brandi M.; Labazi, Hicham; Tostes, Rita de Cassia Aleixo; Webb, R. Clinton
Source: Pharmacological Research. Unidade: FMRP
Subjects: AORTA, ANGIOTENSINA II, HIPERTENSÃO, ÓXIDO NÍTRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WYNNE, Brandi M. et al. Aorta from angiotensin II hypertensive mice exhibit preserved nitroxyl anion mediated relaxation responses. Pharmacological Research, v. 65, n. 1, p. 41-47, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.phrs.2011.07.002. Acesso em: 16 nov. 2024.
APA
Wynne, B. M., Labazi, H., Tostes, R. de C. A., & Webb, R. C. (2012). Aorta from angiotensin II hypertensive mice exhibit preserved nitroxyl anion mediated relaxation responses. Pharmacological Research, 65( 1), 41-47. doi:10.1016/j.phrs.2011.07.002
NLM
Wynne BM, Labazi H, Tostes R de CA, Webb RC. Aorta from angiotensin II hypertensive mice exhibit preserved nitroxyl anion mediated relaxation responses [Internet]. Pharmacological Research. 2012 ; 65( 1): 41-47.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.phrs.2011.07.002
Vancouver
Wynne BM, Labazi H, Tostes R de CA, Webb RC. Aorta from angiotensin II hypertensive mice exhibit preserved nitroxyl anion mediated relaxation responses [Internet]. Pharmacological Research. 2012 ; 65( 1): 41-47.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.phrs.2011.07.002
Artigo de periodico
Time course involvement of matrix metalloproteinases in the vascular alterations of renovascular hypertension (2012)
Ceron, Carla S.; Rizzi, Elen; Guimarães, Danielle A.; Martins-Oliveira, Alisson; Cau, Stefany B.; Ramos, Junia; Gerlach, Raquel Fernanda; Tanus-Santos, José Eduardo
Source: Matrix Biology. Unidades: FMRP, FORP
Subjects: METALOPROTEINASES, ESTRESSE OXIDATIVO, INIBIDORES DE ENZIMAS, ANGIOTENSINA II, AORTA TORÁCICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERON, Carla S. et al. Time course involvement of matrix metalloproteinases in the vascular alterations of renovascular hypertension. Matrix Biology, v. 31, n. 4, p. 261-270, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.matbio.2012.01.009. Acesso em: 16 nov. 2024.
APA
Ceron, C. S., Rizzi, E., Guimarães, D. A., Martins-Oliveira, A., Cau, S. B., Ramos, J., et al. (2012). Time course involvement of matrix metalloproteinases in the vascular alterations of renovascular hypertension. Matrix Biology, 31( 4), 261-270. doi:10.1016/j.matbio.2012.01.009
NLM
Ceron CS, Rizzi E, Guimarães DA, Martins-Oliveira A, Cau SB, Ramos J, Gerlach RF, Tanus-Santos JE. Time course involvement of matrix metalloproteinases in the vascular alterations of renovascular hypertension [Internet]. Matrix Biology. 2012 ; 31( 4): 261-270.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.matbio.2012.01.009
Vancouver
Ceron CS, Rizzi E, Guimarães DA, Martins-Oliveira A, Cau SB, Ramos J, Gerlach RF, Tanus-Santos JE. Time course involvement of matrix metalloproteinases in the vascular alterations of renovascular hypertension [Internet]. Matrix Biology. 2012 ; 31( 4): 261-270.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.matbio.2012.01.009
Trabalho de evento-resumo
Caspase-1 activation contributes to angiotensin-II-induced vascular dysfunction and hypertension (2012)
Cau, Stefany B.; Silva, Marcondes A.; Coimbra, Terezila Machado; Alves Filho, José Carlos; Zamboni, Dario Simões; Tostes, Rita de Cassia Aleixo
Source: Final Program. Conference titles: High Blood Pressure Research Scientific Sessions (HBPR). Unidade: FMRP
Subjects: SISTEMA CARDIOVASCULAR, HIPERTENSÃO, ANGIOTENSINA II
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAU, Stefany B. et al. Caspase-1 activation contributes to angiotensin-II-induced vascular dysfunction and hypertension. 2012, Anais.. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 2012. . Acesso em: 16 nov. 2024.
APA
Cau, S. B., Silva, M. A., Coimbra, T. M., Alves Filho, J. C., Zamboni, D. S., & Tostes, R. de C. A. (2012). Caspase-1 activation contributes to angiotensin-II-induced vascular dysfunction and hypertension. In Final Program. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Cau SB, Silva MA, Coimbra TM, Alves Filho JC, Zamboni DS, Tostes R de CA. Caspase-1 activation contributes to angiotensin-II-induced vascular dysfunction and hypertension. Final Program. 2012 ;[citado 2024 nov. 16 ]
Vancouver
Cau SB, Silva MA, Coimbra TM, Alves Filho JC, Zamboni DS, Tostes R de CA. Caspase-1 activation contributes to angiotensin-II-induced vascular dysfunction and hypertension. Final Program. 2012 ;[citado 2024 nov. 16 ]

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration